
2027 Future Talent Program - Global Communications - Intern
Merck
Summary
The Future Talent Program features internships that last up to 12 weeks and will include one or more projects. Our company's Global Communications organization has an opportunity for a summer 2027 communications intern. This individual will support internal communications for major transformation initiatives across our organization, including work related to AI-enabled capabilities.
Job description
Responsibilities
- Collaborate with the Human Health Communications team to support delivery of our U.S. customer engagement transformation communications strategy
- Apply an AI-first mindset across communications work, using generative AI tools to support research, content development, collaboration and more efficient ways of working
- Support planning and execution of employee engagement moments, from agenda development, briefing materials and recaps for events to video shoot preparation and execution
- Contribute to Human Health newsletters and quarterly messages, including drafting, sourcing stories and coordinating inputs and edits
- Partner with cross-functional subject matter experts across change management, program management, strategy realization and other functional teams to gather and incorporate input into communications materials
- Conduct research on change communications practices, employee experience and AI adoption in the workplace to inform our approach
- Support measurement of communications effectiveness through coordinated listening channels, tracking and synthesizing data including open rates, click-through rates, event attendance, survey results and sentiment
- Assist with the Global Diversity & Inclusion Experience Month, supporting content development, event promotion and toolkit materials
- Help maintain existing SharePoint sites so employees can easily find current, accurate information about transformation programs
Required experience and education
- Candidates must be currently in their junior year or above pursuing a college degree preferably in a related field (e.g., Business, English, Marketing/Communications)
- Candidates must be available to work full-time for the summer months beginning in May 2027 through August 2027
Preferred qualifications
- Experience with Microsoft Teams, SharePoint or other digital collaboration platforms preferred
- Familiarity with generative AI tools and an interest in their application to communications preferred
- Coursework or demonstrated interest in organizational change, business transformation, public health, life sciences or healthcare communications preferred
- Experience working in team environments and collaborating with diverse groups preferred
Requirements
- Currently in junior year or above pursuing a college degree
- Degree preferably in a related field (e.g., Business, English, Marketing/Communications)
- Available to work full-time for summer months beginning May 2027 through August 2027
- Strong writing skills
- Experience with Microsoft Teams, SharePoint or other digital collaboration platforms preferred
- Familiarity with generative AI tools preferred
- Coursework or demonstrated interest in organizational change, business transformation, public health, life sciences or healthcare communications preferred
- Experience working in team environments and collaborating with diverse groups preferred
Benefits
- Hybrid work arrangement
- No relocation
- No travel required
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.